The mission of the ACTG Network is to develop and conduct scientifically rigorous translational research and clinical trials by:
- Investigating the viral and immune pathogenesis of HIV-1 infection and its complications.
- Evaluating novel drugs and strategies for treating HIV-1 infection.
- Evaluating interventions and strategies to treat and prevent HIV-related co-infections and co-morbidity.
- Publishing and disseminating results to improve care, and reduce or eliminate morbidity and mortality associated with HIV-1 infection and its complications.
Community members interested in participating in an ACTG study should contact the Screening Coordinator at (619) 543-3196.
Page 'Breadcrumb' Navigation: